IDO-silenced cancer immunotherapeutic (Regen Biopharm)

N/A

Report date: 2024/09/24 10:49:38

Base Information

Drug NameIDO-silenced cancer immunotherapeutic (Regen Biopharm)
Drug Alias NameGene Silencing of IDO (Regen Biopharm)dCellVax (Regen Biopharm)
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionDendritic cells modulatorsGene silencingRNA interference +[4] 
TargetsUpdating
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRegen Biopharma
China Registration ClassN/A

Develop Information

Active CompaniesRegen Biopharma
Inactive CompaniesN/A
Active IndicationsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A